US5962490A
(en)
*
|
1987-09-25 |
1999-10-05 |
Texas Biotechnology Corporation |
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5514691A
(en)
*
|
1993-05-20 |
1996-05-07 |
Immunopharmaceutics, Inc. |
N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5594021A
(en)
*
|
1993-05-20 |
1997-01-14 |
Texas Biotechnology Corporation |
Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5571821A
(en)
*
|
1993-05-20 |
1996-11-05 |
Texas Biotechnology Corporation |
Sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5591761A
(en)
*
|
1993-05-20 |
1997-01-07 |
Texas Biotechnology Corporation |
Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5736509A
(en)
*
|
1990-12-14 |
1998-04-07 |
Texas Biotechnology Corporation |
Cyclic peptide surface feature mimics of endothelin
|
US5817693A
(en)
|
1991-11-05 |
1998-10-06 |
Cousins; Russell Donovan |
Endothelin receptor antagonists
|
US5378715A
(en)
*
|
1992-02-24 |
1995-01-03 |
Bristol-Myers Squibb Co. |
Sulfonamide endothelin antagonists
|
US5514696A
(en)
*
|
1992-05-06 |
1996-05-07 |
Bristol-Myers Squibb Co. |
Phenyl sulfonamide endothelin antagonists
|
AU4376893A
(en)
*
|
1992-05-19 |
1993-12-13 |
Immunopharmaceutics, Inc. |
Compounds that modulate endothelin activity
|
ES2062927B1
(es)
*
|
1992-12-17 |
1995-07-01 |
Smithkline Beecham Corp |
Antagonistas de los receptores de endotelina y procedimiento para su preparacion.
|
US5767310A
(en)
*
|
1993-03-19 |
1998-06-16 |
Merck & Co., Inc. |
Phenoxyphenylacetic acid derivatives
|
GB9307694D0
(en)
|
1993-04-14 |
1993-06-02 |
Smithkine Beecham Corp |
Novel compounds
|
FI941826A
(fi)
|
1993-04-21 |
1994-10-22 |
Takeda Chemical Industries Ltd |
Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi
|
BR9406572A
(pt)
*
|
1993-04-27 |
1996-01-30 |
Smithkline Beecham Corp |
Antagonistas receptores do endotelin
|
US6030991A
(en)
*
|
1993-05-20 |
2000-02-29 |
Texas Biotechnology Corp. |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US6087324A
(en)
*
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
US5686478A
(en)
*
|
1993-07-20 |
1997-11-11 |
Merck & Co. Inc. |
Endothelin antagonists
|
US5817653A
(en)
*
|
1993-08-06 |
1998-10-06 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
EP0711157A4
(en)
*
|
1993-08-06 |
1996-07-31 |
Smithkline Beecham Corp |
ENDOTHELIN RECEPTOR ANTAGONISTS
|
JP2847969B2
(ja)
*
|
1993-08-18 |
1999-01-20 |
萬有製薬株式会社 |
エンドセリン拮抗活性を有する複素芳香環縮合シクロペンテン誘導体
|
US5714479A
(en)
*
|
1993-08-18 |
1998-02-03 |
Banyu Pharmaceutical Co., Ltd. |
Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
|
US5389620A
(en)
*
|
1993-08-18 |
1995-02-14 |
Banyu Pharmaceutical Co., Ltd. |
Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
|
US6140325A
(en)
*
|
1993-08-19 |
2000-10-31 |
Takeda Chemical Industries, Ltd. |
Thienopyrimidine derivatives, their production and use
|
US5965732A
(en)
*
|
1993-08-30 |
1999-10-12 |
Bristol-Myers Squibb Co. |
Sulfonamide endothelin antagonists
|
CA2173875A1
(en)
*
|
1993-11-01 |
1995-05-11 |
Hideyuki Saika |
Endothelin receptor antagonists
|
US6063911A
(en)
*
|
1993-12-01 |
2000-05-16 |
Marine Polymer Technologies, Inc. |
Methods and compositions for treatment of cell proliferative disorders
|
EP0763035A4
(en)
*
|
1994-06-09 |
1997-10-01 |
Smithkline Beecham Corp |
ENDOTHELIN RECEPTOR ANTAGONISTS
|
EP0768878A4
(en)
*
|
1994-06-20 |
1999-02-17 |
Smithkline Beecham Corp |
ENDOTHELINE RECEPTOR ANTAGONISTS
|
US5767144A
(en)
*
|
1994-08-19 |
1998-06-16 |
Abbott Laboratories |
Endothelin antagonists
|
ES2179881T3
(es)
*
|
1994-08-19 |
2003-02-01 |
Abbott Lab |
Antagonistas de endotelina.
|
US7208517B1
(en)
|
1994-08-19 |
2007-04-24 |
Abbott Labortories |
Endothelin antagonists
|
US6162927A
(en)
|
1994-08-19 |
2000-12-19 |
Abbott Laboratories |
Endothelin antagonists
|
US5612359A
(en)
*
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
US5559135A
(en)
*
|
1994-09-14 |
1996-09-24 |
Merck & Co., Inc. |
Endothelin antagonists bearing pyridyl amides
|
US5538991A
(en)
*
|
1994-09-14 |
1996-07-23 |
Merck & Co., Inc. |
Endothelin antagonists bearing 5-membered heterocyclic amides
|
US5482960A
(en)
*
|
1994-11-14 |
1996-01-09 |
Warner-Lambert Company |
Nonpeptide endothelin antagonists
|
JPH10512855A
(ja)
*
|
1994-12-23 |
1998-12-08 |
スミスクライン・ビーチャム・コーポレイション |
化合物および方法
|
US5780473A
(en)
*
|
1995-02-06 |
1998-07-14 |
Bristol-Myers Squibb Company |
Substituted biphenyl sulfonamide endothelin antagonists
|
US5760038A
(en)
*
|
1995-02-06 |
1998-06-02 |
Bristol-Myers Squibb Company |
Substituted biphenyl sulfonamide endothelin antagonists
|
US5599811A
(en)
*
|
1995-02-21 |
1997-02-04 |
Warner-Lambert Company |
Benzothiazine dioxides as endothelin antagonists
|
EP0757055B1
(de)
*
|
1995-06-30 |
1999-10-27 |
Cerbios-Pharma S.A. |
Glykoside, deren zuckerfreie Abbauprodukte und Derivate derselben
|
DE19527568A1
(de)
*
|
1995-07-28 |
1997-01-30 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
US5846990A
(en)
*
|
1995-07-24 |
1998-12-08 |
Bristol-Myers Squibb Co. |
Substituted biphenyl isoxazole sulfonamides
|
DE19530032A1
(de)
*
|
1995-08-16 |
1997-02-20 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
AU6670196A
(en)
*
|
1995-08-17 |
1997-03-12 |
Takeda Chemical Industries Ltd. |
Thienopyrimidine derivatives, their production and use
|
DE19537548A1
(de)
*
|
1995-10-09 |
1997-04-10 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
JPH09124620A
(ja)
|
1995-10-11 |
1997-05-13 |
Bristol Myers Squibb Co |
置換ビフェニルスルホンアミドエンドセリン拮抗剤
|
US6162932A
(en)
*
|
1995-11-08 |
2000-12-19 |
Smithkline Beecham Corporation |
Stereoselective synthesis of endothelin receptor antagonists
|
CA2236924A1
(en)
*
|
1995-11-08 |
1997-05-15 |
Smithkline Beecham Corporation |
Stereoselective synthesis of endothelin receptor antagonists
|
US6147232A
(en)
|
1995-11-08 |
2000-11-14 |
Smithkline Beecham Corporation |
Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
|
AU1054297A
(en)
*
|
1995-11-08 |
1997-05-29 |
Smithkline Beecham Corporation |
A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
|
US6080862A
(en)
*
|
1995-11-08 |
2000-06-27 |
Smithkline Beecham Corporation |
Stereoselective synthesis of endothelin receptor antagonists
|
ZA969363B
(en)
*
|
1995-11-08 |
1997-11-18 |
Smithkline Beecham Corp |
An improved process for preparing aromatic ring-fused cyclopentane derivatives.
|
DE19543639A1
(de)
*
|
1995-11-23 |
1997-05-28 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
US5977117A
(en)
*
|
1996-01-05 |
1999-11-02 |
Texas Biotechnology Corporation |
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
|
NZ503383A
(en)
*
|
1996-02-13 |
2002-02-01 |
Abbott Lab |
Method for contracting non-vascular smooth muscle using ethyl 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-4,5-dihydro-3H-pyrrole-3-carboxlylate
|
PT885215E
(pt)
*
|
1996-02-13 |
2006-08-31 |
Abbott Lab |
Novos derivados de pirrolidina substituidos com benzo-1,3-dioxolilo e benzofuranilo como antagonistas de endotelina
|
US5856507A
(en)
*
|
1997-01-21 |
1999-01-05 |
Bristol-Myers Squibb Co. |
Methods for the preparation of biphenyl isoxazole sulfonamides
|
JP2001523218A
(ja)
|
1996-02-20 |
2001-11-20 |
ブリストル―マイヤーズ・スクイブ・カンパニー |
ビフェニルイソキサゾール・スルホンアミドの製造法
|
US5958905A
(en)
*
|
1996-03-26 |
1999-09-28 |
Texas Biotechnology Corporation |
Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
|
US5939446A
(en)
*
|
1996-04-09 |
1999-08-17 |
Bristol-Myers Squibb Co. |
Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
|
US5804585A
(en)
*
|
1996-04-15 |
1998-09-08 |
Texas Biotechnology Corporation |
Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
|
EP0912534B1
(en)
*
|
1996-07-01 |
2002-09-25 |
Schering Corporation |
Muscarinic antagonists
|
US5935958A
(en)
*
|
1996-07-01 |
1999-08-10 |
Schering Corporation |
Muscarinic antagonists
|
JPH11514676A
(ja)
*
|
1996-08-09 |
1999-12-14 |
メルク エンド カンパニー インコーポレーテッド |
立体選択的脱酸素化反応
|
US6172235B1
(en)
|
1996-08-09 |
2001-01-09 |
Merck & Co., Inc. |
Asymmetric conjugate addition reaction
|
ES2207747T3
(es)
*
|
1996-08-09 |
2004-06-01 |
MERCK & CO., INC. |
Reaccion de adicion de conjugado asimetrico.
|
KR100343832B1
(ko)
|
1996-08-27 |
2002-07-20 |
시오노기세이야쿠가부시키가이샤 |
크로멘-3-카르복실산 유도체
|
DE19653024A1
(de)
*
|
1996-12-19 |
1998-06-25 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
TW432028B
(en)
*
|
1997-01-14 |
2001-05-01 |
Merck & Co Inc |
Asymmetric conjugate addition reaction using a chiral additive
|
US5998625A
(en)
*
|
1997-01-14 |
1999-12-07 |
Merck & Co., Inc. |
Asymmetric conjugate addition reaction using a chiral additive
|
TW536540B
(en)
*
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
AU6187898A
(en)
*
|
1997-01-30 |
1998-08-25 |
Bristol-Myers Squibb Company |
Method for preventing or treating low renin hypertension by administering an endothelin antagonist
|
US5783705A
(en)
|
1997-04-28 |
1998-07-21 |
Texas Biotechnology Corporation |
Process of preparing alkali metal salys of hydrophobic sulfonamides
|
US6013674A
(en)
*
|
1997-06-02 |
2000-01-11 |
Eli Lilly And Company |
Cell adhesion inhibitors
|
JP4058507B2
(ja)
|
1997-07-10 |
2008-03-12 |
国立大学法人 東京医科歯科大学 |
4,5−ジヒドロ−[1H]−ベンズ[g]インダゾール−3−カルボン酸誘導体
|
US6022972A
(en)
|
1997-08-08 |
2000-02-08 |
Merck & Co., Inc. |
Pyridine propanoic acid derivatives
|
US5929106A
(en)
*
|
1997-10-27 |
1999-07-27 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
DE69914880T2
(de)
*
|
1998-01-21 |
2004-08-05 |
Banyu Pharmaceutical Co., Ltd. |
Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
|
AR022228A1
(es)
|
1999-01-12 |
2002-09-04 |
Abbott Gmbh & Co Kg |
Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion
|
HUP0201320A2
(en)
|
1999-03-19 |
2002-08-28 |
Bristol Myers Squibb Co |
Methods for the preparation of biphenyl isoxazole sulfonamides and intermediates thereof
|
US7566452B1
(en)
|
1999-05-04 |
2009-07-28 |
New York University |
Cancer treatment with endothelin receptor antagonists
|
CA2373210A1
(en)
*
|
1999-05-26 |
2000-12-07 |
Warner-Lambert Company |
Fused polycyclic amino acids as pharmaceutical agents
|
EP1194400A1
(en)
|
1999-06-30 |
2002-04-10 |
Prescient Neuropharma Inc. |
2-aminoindane analogs
|
CA2395684C
(en)
|
1999-12-31 |
2012-01-03 |
Texas Biotechnology Corporation |
Sulfonamides and derivatives thereof that modulate the activity of endothelin
|
UA104987C2
(ru)
|
2001-06-12 |
2014-04-10 |
Уеллстат Терепьютікс Корпорейшн |
Производные 3-(2,6-диметилбензилокси)фенилуксусной кислоты
|
US7772240B2
(en)
|
2003-08-18 |
2010-08-10 |
H. Lundbeck A/S |
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
KR100595963B1
(ko)
*
|
2004-04-13 |
2006-07-05 |
한국화학연구원 |
인덴 유도체 및 이의 제조방법
|
AU2005318598B2
(en)
|
2004-12-21 |
2010-08-26 |
F. Hoffmann-La Roche Ag |
Tetralin and indane derivatives and uses thereof as 5-HT antagonists
|
TWI376373B
(en)
|
2005-02-16 |
2012-11-11 |
Lundbeck & Co As H |
Crystalline base of a pharmaceutical compound
|
TWI453198B
(zh)
|
2005-02-16 |
2014-09-21 |
Lundbeck & Co As H |
製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
|
EP3000487B8
(en)
|
2007-02-19 |
2022-06-15 |
Marine Polymer Technologies, Inc. |
Hemostatic compositions and therapeutic regimens
|
NZ602909A
(en)
|
2010-04-15 |
2015-01-30 |
Marinepolymer Tech Inc |
Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
|
JP6144254B2
(ja)
|
2011-04-15 |
2017-06-07 |
マリン ポリマー テクノロジーズ,インコーポレーテッド |
ポリ−n−アセチルグルコサミンナノファイバを用いた疾患の治療
|
CN110343038B
(zh)
*
|
2018-04-02 |
2022-03-15 |
暨南大学 |
一种宝乐果单体、提取物及其制备方法和应用
|
WO2023283425A1
(en)
|
2021-07-09 |
2023-01-12 |
Plexium, Inc. |
Aryl compounds and pharmaceutical compositions that modulate ikzf2
|
WO2024005578A1
(ko)
*
|
2022-06-29 |
2024-01-04 |
아밀로이드솔루션 주식회사 |
신규 인덴온 유도체 및 이의 용도
|